Literature DB >> 16698115

Evaluating mobility for radiotherapy planning of lung tumors: a comparison of virtual fluoroscopy and 4DCT.

Ylanga G van der Geld1, Suresh Senan, John R van Sörnsen de Koste, Harm van Tinteren, Ben J Slotman, René W M Underberg, Frank J Lagerwaard.   

Abstract

PURPOSE: Fluoroscopy is widely used for evaluating tumor mobility in radiotherapy planning. Lung tumor mobility was scored using virtual fluoroscopy, and this was compared to mobility derived from contoured tumors in all phases of a respiration-correlated (or 4D) CT scan. METHODS AND MATERIALS: 4DCT datasets were reviewed and 29 patients were identified in whom tumors were visible on anterior-posterior fluoroscopy views. Mobility in all directions was estimated on fluoroscopy movie loops by four clinicians. These results were compared to mobility measured from contoured tumor volumes in all phases of the same 4DCT. Internal target volumes (ITV) were generated for both approaches.
RESULTS: In eight patients, fluoroscopy did not allow for tumor mobility to be assessed in at least one direction. No significant inter-clinician variation was observed with respect to fluoroscopic assessment of mobility. Clinicians systematically overestimated mobility in all three directions (p<0.05). The mean ITVs derived using fluoroscopy were 52.2% larger than those derived using 4DCT contours, but the individual ITVs were smaller in three patients.
CONCLUSION: Use of virtual fluoroscopy generally overestimates the mobility of visible lung tumors, and results in irradiation of unnecessarily large target volumes. In contrast, use of 4DCT minimizes the risk of normal tissue toxicity.

Entities:  

Mesh:

Year:  2006        PMID: 16698115     DOI: 10.1016/j.lungcan.2006.03.013

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  5 in total

1.  Imaging for high-precision thoracic radiotherapy.

Authors:  Sashendra Senthi; Suresh Senan
Journal:  J Thorac Dis       Date:  2012-04-01       Impact factor: 2.895

2.  How does four-dimensional computed tomography spare normal tissues in non-small cell lung cancer radiotherapy by defining internal target volume?

Authors:  Tong Bai; Jian Zhu; Yong Yin; Jie Lu; Huazhong Shu; Lin Wang; Bo Yang
Journal:  Thorac Cancer       Date:  2014-10-23       Impact factor: 3.500

3.  Variables altering the impact of respiratory gated CT simulation on planning target volume in radiotherapy for lung cancer.

Authors:  Fawzi Abuhijla; Abdellatif Al-Mousa; Ramiz Abuhijlih; Lubna Hammoudeh; Khalid Dibs; Adhoob Al-Hammadi; Taher Abuhejleh; Jamal Khader
Journal:  Rep Pract Oncol Radiother       Date:  2019-02-16

4.  Analysis of the advantage of individual PTVs defined on axial 3D CT and 4D CT images for liver cancer.

Authors:  Fengxiang Li; Jianbin Li; Jun Xing; Yingjie Zhang; Tingyong Fan; Min Xu; Dongping Shang; Tonghai Liu; Jinlong Song
Journal:  J Appl Clin Med Phys       Date:  2012-11-08       Impact factor: 2.102

5.  Verifying 4D gated radiotherapy using time-integrated electronic portal imaging: a phantom and clinical study.

Authors:  John R van Sörnsen de Koste; Johan P Cuijpers; Frank G M de Geest; Frank J Lagerwaard; Ben J Slotman; Suresh Senan
Journal:  Radiat Oncol       Date:  2007-08-30       Impact factor: 3.481

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.